Published in Biochemistry on November 14, 2007
Structure of KCNE1 and implications for how it modulates the KCNQ1 potassium channel. Biochemistry (2008) 2.22
Stoichiometry of the KCNQ1 - KCNE1 ion channel complex. Proc Natl Acad Sci U S A (2010) 1.54
Dysfunctional potassium channel subunit interaction as a novel mechanism of long QT syndrome. Heart Rhythm (2013) 1.39
Location of KCNE1 relative to KCNQ1 in the I(KS) potassium channel by disulfide cross-linking of substituted cysteines. Proc Natl Acad Sci U S A (2009) 1.35
Targeting the voltage sensor of Kv7.2 voltage-gated K+ channels with a new gating-modifier. Proc Natl Acad Sci U S A (2010) 1.26
Mechanisms by which atrial fibrillation-associated mutations in the S1 domain of KCNQ1 slow deactivation of IKs channels. J Physiol (2008) 1.22
The S4-S5 linker of KCNQ1 channels forms a structural scaffold with the S6 segment controlling gate closure. J Biol Chem (2010) 1.19
Kv7.1 ion channels require a lipid to couple voltage sensing to pore opening. Proc Natl Acad Sci U S A (2013) 1.18
Structural imperatives impose diverse evolutionary constraints on helical membrane proteins. Proc Natl Acad Sci U S A (2009) 1.08
Identification of a protein-protein interaction between KCNE1 and the activation gate machinery of KCNQ1. J Gen Physiol (2010) 1.06
BCL::Fold--de novo prediction of complex and large protein topologies by assembly of secondary structure elements. PLoS One (2012) 1.00
PIP2 regulation of KCNQ channels: biophysical and molecular mechanisms for lipid modulation of voltage-dependent gating. Front Physiol (2014) 0.97
Small-molecule ligand docking into comparative models with Rosetta. Nat Protoc (2013) 0.96
Biophysical properties of 9 KCNQ1 mutations associated with long-QT syndrome. Circ Arrhythm Electrophysiol (2009) 0.95
Building KCNQ1/KCNE1 channel models and probing their interactions by molecular-dynamics simulations. Biophys J (2013) 0.95
Allosteric features of KCNQ1 gating revealed by alanine scanning mutagenesis. Biophys J (2011) 0.93
Mechanistic basis for LQT1 caused by S3 mutations in the KCNQ1 subunit of IKs. J Gen Physiol (2010) 0.90
Multi-scale electrophysiology modeling: from atom to organ. J Gen Physiol (2010) 0.90
Working model for the structural basis for KCNE1 modulation of the KCNQ1 potassium channel. Curr Opin Struct Biol (2011) 0.90
The KCNE Tango - How KCNE1 Interacts with Kv7.1. Front Pharmacol (2012) 0.89
Personalized biochemistry and biophysics. Biochemistry (2015) 0.88
KCNQ1 channel modulation by KCNE proteins via the voltage-sensing domain. J Physiol (2015) 0.88
Distinct subdomains of the KCNQ1 S6 segment determine channel modulation by different KCNE subunits. J Gen Physiol (2009) 0.87
Purification and structural study of the voltage-sensor domain of the human KCNQ1 potassium ion channel. Biochemistry (2014) 0.87
Voltage-Dependent Gating: Novel Insights from KCNQ1 Channels. Biophys J (2016) 0.87
Opposite Effects of the S4-S5 Linker and PIP(2) on Voltage-Gated Channel Function: KCNQ1/KCNE1 and Other Channels. Front Pharmacol (2012) 0.86
Molecular Pathophysiology of Congenital Long QT Syndrome. Physiol Rev (2017) 0.85
An allosteric mechanism for drug block of the human cardiac potassium channel KCNQ1. Mol Pharmacol (2012) 0.84
Capturing distinct KCNQ2 channel resting states by metal ion bridges in the voltage-sensor domain. J Gen Physiol (2014) 0.83
KCNQ1 subdomains involved in KCNE modulation revealed by an invertebrate KCNQ1 orthologue. J Gen Physiol (2011) 0.80
Identification of a key residue in Kv7.1 potassium channel essential for sensing external potassium ions. J Gen Physiol (2015) 0.80
Regulation of KCNQ/Kv7 family voltage-gated K(+) channels by lipids. Biochim Biophys Acta (2016) 0.79
High-risk long QT syndrome mutations in the Kv7.1 (KCNQ1) pore disrupt the molecular basis for rapid K(+) permeation. Biochemistry (2012) 0.79
The evolutionarily conserved residue A653 plays a key role in HERG channel closing. J Physiol (2009) 0.78
A dual mechanism for I(Ks) current reduction by the pathogenic mutation KCNQ1-S277L. Pacing Clin Electrophysiol (2011) 0.76
Structural basis for KCNE3 modulation of potassium recycling in epithelia. Sci Adv (2016) 0.76
KCNE1 induces fenestration in the Kv7.1/KCNE1 channel complex that allows for highly specific pharmacological targeting. Nat Commun (2016) 0.75
Gating mechanisms underlying deactivation slowing by two KCNQ1 atrial fibrillation mutations. Sci Rep (2017) 0.75
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31
UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem (2004) 112.47
Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol (1999) 33.07
The Amber biomolecular simulation programs. J Comput Chem (2005) 28.84
Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. Science (2005) 17.70
X-ray structure of a voltage-dependent K+ channel. Nature (2003) 14.50
A hidden Markov model for predicting transmembrane helices in protein sequences. Proc Int Conf Intell Syst Mol Biol (1998) 14.18
Native protein sequences are close to optimal for their structures. Proc Natl Acad Sci U S A (2000) 7.99
3D-Jury: a simple approach to improve protein structure predictions. Bioinformatics (2003) 7.99
Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation (2000) 7.50
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science (2003) 6.60
Accurate modeling of protein conformation by automatic segment matching. J Mol Biol (1992) 4.39
Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm (2005) 4.21
Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation (2007) 4.10
Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet (1997) 3.90
Modeling structurally variable regions in homologous proteins with rosetta. Proteins (2004) 3.64
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA (2005) 3.51
Pcons: a neural-network-based consensus predictor that improves fold recognition. Protein Sci (2001) 2.90
The MinK-related peptides. Neuropharmacology (2004) 2.84
Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation (2004) 2.82
Voltage sensor conformations in the open and closed states in ROSETTA structural models of K(+) channels. Proc Natl Acad Sci U S A (2006) 2.81
Multipass membrane protein structure prediction using Rosetta. Proteins (2006) 2.79
KCNQ potassium channels: physiology, pathophysiology, and pharmacology. Pharmacol Ther (2001) 2.78
Physically realistic homology models built with ROSETTA can be more accurate than their templates. Proc Natl Acad Sci U S A (2006) 2.47
De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res (2005) 2.27
The KCNQ1 potassium channel: from gene to physiological function. Physiology (Bethesda) (2005) 2.11
KCNE1 binds to the KCNQ1 pore to regulate potassium channel activity. Neuron (2004) 2.07
Structure prediction meta server. Bioinformatics (2001) 2.02
Prediction of CASP6 structures using automated Robetta protocols. Proteins (2005) 1.94
Coupled prediction of protein secondary and tertiary structure. Proc Natl Acad Sci U S A (2003) 1.90
Structural insight into KCNQ (Kv7) channel assembly and channelopathy. Neuron (2007) 1.81
Charybdotoxin binding in the I(Ks) pore demonstrates two MinK subunits in each channel complex. Neuron (2003) 1.80
A spectrum of functional effects for disease causing mutations in the Jervell and Lange-Nielsen syndrome. Cardiovasc Res (2001) 1.74
KCNE4 is an inhibitory subunit to the KCNQ1 channel. J Physiol (2002) 1.70
Molecular diagnosis in a child with sudden infant death syndrome. Lancet (2001) 1.66
Interaction of KCNE subunits with the KCNQ1 K+ channel pore. J Physiol (2005) 1.66
An improved hidden Markov model for transmembrane protein detection and topology prediction and its applications to complete genomes. Bioinformatics (2005) 1.66
Prediction of protein three-dimensional structures in insertion and deletion regions: a procedure for searching data bases of representative protein fragments using geometric scoring criteria. J Mol Biol (1995) 1.59
Properties of KvLQT1 K+ channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias. EMBO J (1997) 1.55
Structural determinants of KvLQT1 control by the KCNE family of proteins. J Biol Chem (2000) 1.54
MinK subdomains that mediate modulation of and association with KvLQT1. J Gen Physiol (2000) 1.54
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. Circulation (1999) 1.44
Location and orientation of minK within the I(Ks) potassium channel complex. J Biol Chem (2001) 1.40
KCNE3 truncation mutants reveal a bipartite modulation of KCNQ1 K+ channels. J Gen Physiol (2004) 1.40
Genetic causes of hearing loss. N Engl J Med (2000) 1.28
Jervell and Lange-Nielsen syndrome: a Norwegian perspective. Am J Med Genet (1999) 1.28
Mechanisms of I(Ks) suppression in LQT1 mutants. Am J Physiol Heart Circ Physiol (2000) 1.24
Functional effects of mutations in KvLQT1 that cause long QT syndrome. J Cardiovasc Electrophysiol (1999) 1.23
A comprehensive examination of protein sequences for evidence of internal gene duplication. J Mol Evol (1978) 1.14
Identification of specific pore residues mediating KCNQ1 inactivation. A novel mechanism for long QT syndrome. J Biol Chem (2001) 1.12
Abnormal KCNQ1 trafficking influences disease pathogenesis in hereditary long QT syndromes (LQT1). Cardiovasc Res (2005) 1.11
Secondary structure of a KCNE cytoplasmic domain. J Gen Physiol (2006) 1.09
Methods for identifying proteins by using partial sequences. Proc Natl Acad Sci U S A (1979) 1.07
KCNE4 is an inhibitory subunit to Kv1.1 and Kv1.3 potassium channels. Biophys J (2003) 1.03
KCNQ1 gene mutations and the respective genotype-phenotype correlations in the long QT syndrome. Med Sci Monit (2002) 0.99
A recessive variant of the Romano-Ward long-QT syndrome? Circulation (1998) 0.97
Structural determinants and biophysical properties of HERG and KCNQ1 channel gating. J Mol Cell Cardiol (2003) 0.95
Genetic disorders of transporters/channels in the inner ear and their relation to the kidney. Pediatr Nephrol (2004) 0.86
Heterozygous mutation in the pore of potassium channel gene KvLQT1 causes an apparently normal phenotype in long QT syndrome. Eur J Hum Genet (1998) 0.83
Characterization of binding site of closed-state KCNQ1 potassium channel by homology modeling, molecular docking, and pharmacophore identification. Biochem Biophys Res Commun (2005) 0.81
Recognition dynamics up to microseconds revealed from an RDC-derived ubiquitin ensemble in solution. Science (2008) 8.04
ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules. Methods Enzymol (2011) 7.33
Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation (2007) 4.10
PiggyBac transposon-mediated gene transfer in human cells. Mol Ther (2007) 4.07
Molecular basis of an inherited epilepsy. Neuron (2002) 3.77
New algorithms and an in silico benchmark for computational enzyme design. Protein Sci (2006) 3.40
Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest (2003) 3.00
Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation (2002) 2.98
KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. Circulation (2005) 2.78
Rosetta predictions in CASP5: successes, failures, and prospects for complete automation. Proteins (2003) 2.77
Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation (2013) 2.66
Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation (2008) 2.56
Practically useful: what the Rosetta protein modeling suite can do for you. Biochemistry (2010) 2.56
Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study. J Infect Dis (2005) 2.43
Solution nuclear magnetic resonance structure of membrane-integral diacylglycerol kinase. Science (2009) 2.30
Impact of genetics on the clinical management of channelopathies. J Am Coll Cardiol (2013) 2.30
Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation (2007) 2.28
Structure of KCNE1 and implications for how it modulates the KCNQ1 potassium channel. Biochemistry (2008) 2.22
RosettaScripts: a scripting language interface to the Rosetta macromolecular modeling suite. PLoS One (2011) 2.21
Free modeling with Rosetta in CASP6. Proteins (2005) 2.10
Interaction of a G protein with an activated receptor opens the interdomain interface in the alpha subunit. Proc Natl Acad Sci U S A (2011) 2.10
The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol. Science (2012) 2.06
Fibrocystin/polyductin modulates renal tubular formation by regulating polycystin-2 expression and function. J Am Soc Nephrol (2008) 2.04
Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women. Pharmacogenetics (2003) 2.03
Long QT syndrome-associated mutations in intrauterine fetal death. JAMA (2013) 2.00
NOS1AP is a genetic modifier of the long-QT syndrome. Circulation (2009) 2.00
Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome. J Am Coll Cardiol (2008) 1.91
Cardiac ion channels. Annu Rev Physiol (2002) 1.90
De novo high-resolution protein structure determination from sparse spin-labeling EPR data. Structure (2008) 1.84
Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator. Science (2014) 1.81
Myotonia congenita. Adv Genet (2008) 1.80
Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCN1A. J Neurosci (2003) 1.77
Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype. Circulation (2005) 1.77
Expression of multiple KCNE genes in human heart may enable variable modulation of I(Ks). J Mol Cell Cardiol (2005) 1.70
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest (2008) 1.69
A sulfilimine bond identified in collagen IV. Science (2009) 1.69
Polymorphic ventricular tachycardia and KCNJ2 mutations. Heart Rhythm (2004) 1.68
Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation (2002) 1.65
Model-free analysis of protein backbone motion from residual dipolar couplings. J Am Chem Soc (2002) 1.65
Noninactivating voltage-gated sodium channels in severe myoclonic epilepsy of infancy. Proc Natl Acad Sci U S A (2004) 1.65
KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes. Am J Hum Genet (2002) 1.60
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. Heart Rhythm (2008) 1.59
Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome. J Am Coll Cardiol (2012) 1.58
Recent Advances in the Application of Solution NMR Spectroscopy to Multi-Span Integral Membrane Proteins. Prog Nucl Magn Reson Spectrosc (2009) 1.57
Multiplexed transposon-mediated stable gene transfer in human cells. Proc Natl Acad Sci U S A (2010) 1.57
Structural studies of the transmembrane C-terminal domain of the amyloid precursor protein (APP): does APP function as a cholesterol sensor? Biochemistry (2008) 1.54
Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel. Circ Arrhythm Electrophysiol (2008) 1.53
Discovery and characterization of novel subtype-selective allosteric agonists for the investigation of M(1) receptor function in the central nervous system. ACS Chem Neurosci (2010) 1.52
Computational methods in drug discovery. Pharmacol Rev (2013) 1.51
The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum. Nat Genet (2002) 1.51
RosettaEPR: an integrated tool for protein structure determination from sparse EPR data. J Struct Biol (2010) 1.50
NMR assignments for a helical 40 kDa membrane protein. J Am Chem Soc (2004) 1.49
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. Circulation (2005) 1.48
A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes. Circ Cardiovasc Genet (2011) 1.48
Development of a selective small-molecule inhibitor of Kir1.1, the renal outer medullary potassium channel. Mol Pharmacol (2010) 1.45
CASP6 assessment of contact prediction. Proteins (2005) 1.39
Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro. Circulation (2011) 1.38
A model for the solution structure of the rod arrestin tetramer. Structure (2008) 1.37
Preparation, functional characterization, and NMR studies of human KCNE1, a voltage-gated potassium channel accessory subunit associated with deafness and long QT syndrome. Biochemistry (2007) 1.35
Functional zinc finger/sleeping beauty transposase chimeras exhibit attenuated overproduction inhibition. FEBS Lett (2005) 1.35
A thorough dynamic interpretation of residual dipolar couplings in ubiquitin. J Biomol NMR (2006) 1.34
The genetic basis of variability in drug responses. Nat Rev Drug Discov (2002) 1.34
Self-consistent residual dipolar coupling based model-free analysis for the robust determination of nanosecond to microsecond protein dynamics. J Biomol NMR (2008) 1.33
EM-fold: De novo folding of alpha-helical proteins guided by intermediate-resolution electron microscopy density maps. Structure (2009) 1.32
Structural determinants of species-selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studies. Proteins (2009) 1.32
Haplotype diversity in four genes (CLCNKA, CLCNKB, BSND, NEDD4L) involved in renal salt reabsorption. Hum Hered (2007) 1.30
Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential. Neuropharmacology (2010) 1.30
Novel calmodulin mutations associated with congenital arrhythmia susceptibility. Circ Cardiovasc Genet (2014) 1.27
Involvement of distinct arrestin-1 elements in binding to different functional forms of rhodopsin. Proc Natl Acad Sci U S A (2012) 1.27
A correspondence between solution-state dynamics of an individual protein and the sequence and conformational diversity of its family. PLoS Comput Biol (2009) 1.27
Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutants. Circ Res (2014) 1.27
Improved DNA sequencing quality and efficiency using an optimized fast cycle sequencing protocol. Biotechniques (2007) 1.26
Mutant prenyltransferase-like mitochondrial protein (PLMP) and mitochondrial abnormalities in kd/kd mice. Kidney Int (2004) 1.24
Conformation of receptor-bound visual arrestin. Proc Natl Acad Sci U S A (2012) 1.24
Molecular, functional, and genomic characterization of human KCC2, the neuronal K-Cl cotransporter. Brain Res Mol Brain Res (2002) 1.24
Nucleotides and phospholipids compete for binding to the C terminus of KATP channels. Proc Natl Acad Sci U S A (2002) 1.23
Genome-wide association study of multiple congenital heart disease phenotypes identifies a susceptibility locus for atrial septal defect at chromosome 4p16. Nat Genet (2013) 1.23
Divergent biophysical defects caused by mutant sodium channels in dilated cardiomyopathy with arrhythmia. Circ Res (2007) 1.23
Strategy for encoding and comparison of gene expression signatures. Genome Biol (2007) 1.18
Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity. Clin Infect Dis (2006) 1.18
DEER EPR measurements for membrane protein structures via bifunctional spin labels and lipodisq nanoparticles. Biochemistry (2013) 1.17
Genetic variation in the rhythmonome: ethnic variation and haplotype structure in candidate genes for arrhythmias. Pharmacogenomics (2009) 1.16
Identification of Metabotropic Glutamate Receptor Subtype 5 Potentiators Using Virtual High-Throughput Screening. ACS Chem Neurosci (2010) 1.16
EM-fold: de novo atomic-detail protein structure determination from medium-resolution density maps. Structure (2012) 1.15
Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia. J Am Coll Cardiol (2012) 1.15
Benchmarking ligand-based virtual High-Throughput Screening with the PubChem database. Molecules (2013) 1.14
Single-channel properties of human NaV1.1 and mechanism of channel dysfunction in SCN1A-associated epilepsy. J Gen Physiol (2006) 1.14
Solvent accessible surface area approximations for rapid and accurate protein structure prediction. J Mol Model (2009) 1.14